| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Endo International plc | President, CEO, Director | Ordinary Shares | 422,066 | $2,642,133 | $6.26 | 30 Mar 2022 | Direct |
| Endo International plc | President, CEO, Director | Stock Incentive Plan Performance Share Units | 1,342,584 | 30 Mar 2022 | Direct | ||
| Ocugen, Inc. | Director | Option (Right to Buy) | 151,316 | 05 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OCGN | Ocugen, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 09 Jun 2025, 17:19 |
| OCGN | Ocugen, Inc. | 05 Jun 2025 | 0 | $0 | 3 | Director | 09 Jun 2025, 17:18 |
| /report/000159303422000028-coleman-blaise-2022-03-29 | Endo International plc | 29 Mar 2022 | 4 | -$46,806 | 4 | President, CEO, Director | 31 Mar 2022, 16:02 |
| /report/000159303422000019-coleman-blaise-2022-03-05 | Endo International plc | 05 Mar 2022 | 1 | -$74,693 | 4 | President, CEO, Director | 08 Mar 2022, 15:03 |